Lidocaine Hcl 1 % (Vials) Fresenius, Lidocaine Hcl 2 % (Vials) Fresenius 10 mg, 20 mg Solution for injection.
Clinical Summary
Quick overview from the medicine insert
Indication
Local anaesthetic for infiltration, field block, and nerve block.
Dosage (summary)
Dose varies by procedure; max 300 mg/24 hours.
Onset of Action / Duration
Onset: Rapid, Duration: Intermediate
Special Populations
- Elderly
- Debilitated patients
- Children
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Avoid in early pregnancy; crosses into breast milk.
Key Drug Interactions
- Other local anaesthetics
- Antidysrhythmics (e.g., mexiletine)
- Muscle relaxants
- Beta-blockers
- CYP1A2 inhibitors
Contraindications
- Hypersensitivity to lidocaine
- Hypovolaemia
- Complete heart block
- Bradycardia
- Myasthenia gravis
- Porphyria
Common side effects
- Hypotension
- Bradycardia
- Nausea
- Dizziness
- Allergic reactions
Counselling Points
- Avoid driving until fully recovered
- Report any unusual symptoms immediately
- Use caution in patients with cardiac issues
Serious warnings
- Risk of cardiovascular depression
- Monitor blood pressure during spinal anaesthesia
- Potential for serious neurological complications
The Lidocaine Hcl 1 % (Vials) Fresenius, Lidocaine Hcl 2 % (Vials) Fresenius 10 mg, 20 mg Solution for injection. professional information leaflet below is the property of Fresenius Kabi Manufacturing Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.